AT516308T - New immunogenic lipopeptides which contain T helper and b-cell-epitope - Google Patents

New immunogenic lipopeptides which contain T helper and b-cell-epitope

Info

Publication number
AT516308T
AT516308T AT03783851T AT03783851T AT516308T AT 516308 T AT516308 T AT 516308T AT 03783851 T AT03783851 T AT 03783851T AT 03783851 T AT03783851 T AT 03783851T AT 516308 T AT516308 T AT 516308T
Authority
AT
Austria
Prior art keywords
helper
epitope
cell
contain
new immunogenic
Prior art date
Application number
AT03783851T
Other languages
German (de)
Inventor
David Jackson
Weiguang Zeng
Original Assignee
Queensland Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US40283802P priority Critical
Application filed by Queensland Inst Med Res filed Critical Queensland Inst Med Res
Priority to PCT/AU2003/001018 priority patent/WO2004014956A1/en
Publication of AT516308T publication Critical patent/AT516308T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0006Contraceptive vaccins; Vaccines against sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018Lipids, e.g. in lipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6068Other bacterial proteins, e.g. OMP
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AT03783851T 2002-08-12 2003-08-12 New immunogenic lipopeptides which contain T helper and b-cell-epitope AT516308T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US40283802P true 2002-08-12 2002-08-12
PCT/AU2003/001018 WO2004014956A1 (en) 2002-08-12 2003-08-12 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes

Publications (1)

Publication Number Publication Date
AT516308T true AT516308T (en) 2011-07-15

Family

ID=31715903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03783851T AT516308T (en) 2002-08-12 2003-08-12 New immunogenic lipopeptides which contain T helper and b-cell-epitope

Country Status (13)

Country Link
US (2) US7569225B2 (en)
EP (2) EP1543039B1 (en)
JP (2) JP4619120B2 (en)
KR (1) KR101240547B1 (en)
CN (3) CN1688606A (en)
AT (1) AT516308T (en)
AU (1) AU2003250586B2 (en)
BR (1) BR0313154A (en)
CA (1) CA2494192C (en)
DK (1) DK1543039T3 (en)
ES (1) ES2369664T3 (en)
HK (1) HK1113163A1 (en)
WO (1) WO2004014956A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7255867B2 (en) * 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
JP2008510736A (en) * 2004-08-26 2008-04-10 ザ・マクファーレーン・バーネット・インスティテュート・フォー・メディカル・リサーチ・アンド・パブリック・ヘルス・リミテッド Immunotherapy of viral infection
CN101084239A (en) 2004-09-10 2007-12-05 昆士兰医学研究所理事会(Qimr) Truncated LHRH formulations
MX2007007586A (en) * 2004-12-21 2007-12-10 Vaxinnate Corp Compositions of influenza viral proteins and methods of use thereof.
US20080233143A1 (en) * 2005-02-07 2008-09-25 Lipotek Pty Ltd. Adjuvanting Material
CN101151280A (en) * 2005-02-08 2008-03-26 昆士兰医学研究学院委员会 Immunogenic molecules
KR20070122563A (en) 2005-04-19 2007-12-31 일라이 릴리 앤드 캄파니 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
US8420102B2 (en) 2006-03-07 2013-04-16 Vaxinnate Corporation Compositions that include hemagglutinin
WO2008021295A2 (en) 2006-08-14 2008-02-21 Thymon, L.L.C. Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of hiv-1
US20090123488A1 (en) * 2006-08-14 2009-05-14 Thymon, Llc Compositions and methods for the treatment and prophylaxis of Alzheimer's disease
BRPI0604997A (en) 2006-11-30 2007-05-22 Fundacao Zerbini vaccine against beta hemolytic streptococcus of the group, and its acquisition process
US9289485B2 (en) 2006-11-30 2016-03-22 Luiza Guilherme Guglielmi Therapeutic application of S. pyogenes C-terminal peptide
DK2200638T3 (en) * 2007-10-09 2016-06-06 Univ Melbourne Compositions for the transfection of cells
US9138470B2 (en) 2007-11-02 2015-09-22 The Johns Hopkins University Multi-component L2 vaccine for prevention of human papilloma virus infection
US8466259B2 (en) * 2007-12-07 2013-06-18 National Health Research Institutes Adjuvants
US20110262473A1 (en) * 2008-07-07 2011-10-27 The University Of Melbourne Synthetic vaccine component
US8846388B2 (en) 2009-10-16 2014-09-30 Zoetis Llc Infectious clones of torque teno virus
CN102256997A (en) 2008-10-16 2011-11-23 美国辉瑞有限公司 Torque teno virus (ttv) isolates and compositions
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
EA201101015A1 (en) * 2008-12-29 2012-02-28 Лонца Брен Са A method for producing bivalirudin
JP2012523379A (en) 2009-04-09 2012-10-04 ザ ユニバーシティー オブ メルボルン Immunogenic compositions and the use thereof
US8287880B2 (en) 2009-06-02 2012-10-16 National Health Research Institutes Lipidated vaccine against dengue virus infection
EP2445927B1 (en) * 2009-06-22 2014-04-23 National Health Research Institutes Lipidated tumor- associated antigens and immunotherapeutic compositions
DE102009034779A1 (en) 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetic analogs of bacterial lipopeptides and their use for the treatment and prevention of allergic diseases
US20130039939A1 (en) 2009-12-28 2013-02-14 Thomas Ebensen Lipopeptide- and lipoprotein-conjugates and its use
US20130142827A1 (en) * 2010-06-25 2013-06-06 Philadelphia Health & Education Corporation D/B/A Induction of immune response
CN103179977B (en) * 2010-08-27 2016-10-26 潘塔希生物科学股份有限公司 Immunotherapy treatment for prostate cancer
AU2011305061B2 (en) * 2010-09-22 2016-04-14 Ena Therapeutics Pty Ltd Novel immunostimulatory method
TW201221642A (en) 2010-11-15 2012-06-01 Nat Health Research Institutes Method of producing lipidated polypeptides
TWI507413B (en) 2010-11-15 2015-11-11 Nat Health Research Institutes Lipidated polyepitope vaccines
DE102011018499A1 (en) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topical nanoparticle vaccine for immune stimulation of dendritic cells in the skin
WO2012162628A2 (en) * 2011-05-25 2012-11-29 Calidris Therapeutics, Ltd. Lipopeptide inhibitors of ras oncoproteins
EP2718429A1 (en) 2011-06-08 2014-04-16 Zoetis LLC Infectious clones of torque teno virus
EA201492262A1 (en) * 2012-06-06 2015-08-31 Бионор Иммуно Ас The design of peptide backbone
AU2012394394A1 (en) * 2012-11-16 2015-06-04 United Biomedical, Inc. Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)
WO2015157189A1 (en) * 2014-04-07 2015-10-15 The Regents Of The University Of California Vaccines and uses thereof
RU2017126206A (en) 2014-12-23 2019-01-25 Маргарет Анне БРИМБЛЕ The amino acid and peptide conjugates and direction of their use
WO2017073797A1 (en) * 2015-10-28 2017-05-04 Ajinomoto Co., Inc. Immunostimulating agent
EP3432922A1 (en) 2016-03-21 2019-01-30 South Dakota Board of Regents Orf virus-based platform for vaccine delivery
DE102016005550A1 (en) 2016-05-09 2017-11-09 Emc Microcollections Gmbh Adjuvant to lnduzierung a cellular immune response
CN107703294A (en) * 2017-10-12 2018-02-16 华派生物工程集团有限公司 ELISA method for detecting titer of cLHRH antibody in chicken serum

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US6024964A (en) 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US5864008A (en) 1988-03-25 1999-01-26 James; Stephen Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
DE4119856A1 (en) 1991-06-17 1992-12-24 Hoechst Ag N-acyl-S- (2-hydroxyalkyl) -cysteine, vaccines their preparation and their use as intermediates for the preparation of synthetic immunoadjuvants and synthetic
GB9202219D0 (en) 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
WO1993022343A1 (en) 1992-05-01 1993-11-11 The Rockfeller University Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
AUPM885194A0 (en) 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
US5807978A (en) 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
US6048538A (en) 1997-10-03 2000-04-11 United Biomedical, Inc. Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents
US6107021A (en) 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
EP1147212B1 (en) 1999-02-05 2009-08-26 The University Of Melbourne T helper cell epitopes
US20020018806A1 (en) 2000-03-24 2002-02-14 Babita Agrawal Lipopeptide adjuvants

Also Published As

Publication number Publication date
EP1543039A1 (en) 2005-06-22
CN1688606A (en) 2005-10-26
WO2004014956A1 (en) 2004-02-19
US7569225B2 (en) 2009-08-04
KR20050053608A (en) 2005-06-08
ES2369664T3 (en) 2011-12-02
DK1543039T3 (en) 2011-10-31
CA2494192C (en) 2013-01-22
EP2301972A1 (en) 2011-03-30
EP1543039A4 (en) 2007-09-19
CN101121754B (en) 2012-02-29
US20100092500A1 (en) 2010-04-15
JP5265511B2 (en) 2013-08-14
US20070066534A1 (en) 2007-03-22
AU2003250586B2 (en) 2010-09-23
CA2494192A1 (en) 2004-02-19
CN101121754A (en) 2008-02-13
EP1543039B1 (en) 2011-07-13
HK1113163A1 (en) 2012-12-07
CN1688606B (en) 2013-12-25
BR0313154A (en) 2005-08-02
US8367067B2 (en) 2013-02-05
JP2006513140A (en) 2006-04-20
KR101240547B1 (en) 2013-03-08
JP2010155832A (en) 2010-07-15
AU2003250586A1 (en) 2004-02-25
JP4619120B2 (en) 2011-01-26

Similar Documents

Publication Publication Date Title
DK1946771T3 (en) Multivalent vaccine composition
NO20160963A1 (en) Highly concentrated antibody and protein formulations.
DE50109908D1 (en) Bone implant, in particular intervertebral implant
DE60202518D1 (en) Intervertebral implant with selbstblockierendem fasteners
DE60202027D1 (en) Multi-photon endoscope
RU2003129502A (en) The compound, pharmaceutical composition, use, method of treatment or prevention of diseases
DE602004030070D1 (en) Between the implant.
DE60239794D1 (en) Spherical spinal implant
NO20031018D0 (en) Oksymorfonpreparater controlled release
IS2944B (en) The polymer-conjugates of reduced antigenicity, methods of preparation and their use
DK1463462T3 (en) Prosthetic heart valve system
DE60318061D1 (en) fusion implant
ITTO20000780A1 (en) Pharmaceutical compositions.
RU2004136572A (en) System for the treatment of obesity and an implant for use in such a system
DK1663287T3 (en) Use of modified cyclosporins in the treatment of HCV disease
NO20034056D0 (en) proliferative diseases
DE122011100054I1 (en) Influenza vaccine compositions for intradermal administration.
FR2847800B1 (en) interchangeable prosthetic valve
DE50313446D1 (en) Intervertebral implant
DE50309438D1 (en) Intervertebral implant
DE50308869D1 (en) Intervertebral implant
NO20050426L (en) Arylkarbonylderivater as therapeutic agents
DE60223269D1 (en) Dosage forms for the modified release
DE50212036D1 (en) Intervertebral implant
DE50212250D1 (en) Intervertebral implant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1543039

Country of ref document: EP